Granted Patent
Utility
US 5,866,125 · App. 08/634,224
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
Inventors:
Peter Brams, Soulaima Salim Chamat, Li Pan, Edward E. Walsh, Cheryl Heard, Roland A. Newman
Patented Case
View Patent ↗
Granted: Feb 2, 1999
Filed: Apr 18, 1996
Inventors
Peter Brams
Soulaima Salim Chamat
Li Pan
Edward E. Walsh
Cheryl Heard
Roland A. Newman
Assignee (at issue)
IDEC Pharmaceuticals Corporation
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.